HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Overexpression of phosphorylated-STAT3 and phosphorylated-ERK protein in dermatofibrosarcoma protuberans.

Abstract
The overexpression of phosphorylated signal transducer and activator of transcription-3 (p-STAT3) and phosphorylated extracellular signal-regulated kinase (p-ERK) have recently been shown to play an important role in the pathogenesis of various human tumors. However, the role of these two major signal transduction pathways in dermatofibrosarcoma protuberans (DFSP) remains unknown. This study was designed to investigate the significance of p-STAT3 and p-ERK expression in DFSP. The expressions of p-STAT3 and p-ERK were analyzed by immunohistochemical staining in formalin-fixed, paraffin-embedded tissue sections of human DFSP and dermatofibroma. Ten cases were positive for p-STAT3 expression in 14 cases of DFSP, however, only 5 cases were positive in 20 cases of dermatofibroma. Eleven out of 14 cases of DFSP expressed p-ERK, but only four cases were positive in 20 cases of dermatofibroma. The expressions of p-STAT3 and p-ERK were significantly higher than those in dermatofibroma (both p < 0.01). This study suggests that the overexpression of p-STAT3 and p-ERK may play a pivotal role in the oncogenesis of DFSP.
AuthorsNengxing Lin, Kazunori Urabe, Yoichi Moroi, Hiroshi Uchi, Takeshi Nakahara, Teruki Dainichi, Hisashi Kokuba, Yating Tu, Masutaka Furue
JournalEuropean journal of dermatology : EJD (Eur J Dermatol) 2006 May-Jun Vol. 16 Issue 3 Pg. 262-5 ISSN: 1167-1122 [Print] France
PMID16709490 (Publication Type: Journal Article)
Chemical References
  • STAT3 Transcription Factor
  • Extracellular Signal-Regulated MAP Kinases
Topics
  • Adult
  • Aged
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Female
  • Histiocytoma, Benign Fibrous (enzymology, metabolism)
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Phosphorylation
  • STAT3 Transcription Factor (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: